Health Care DSP DeepIntent Sells $637 Million Majority Stake To PE Firm Vitruvian Partners
Private equity firm Vitruvian Partners backs DeepIntent with $637 million bet on programmatic privacy-compliant health care ads.
ARCHIVE FOR:
programmatic pharma
-
-
OPINION: On TV & VideoLinear Is Still The King Of Pharma, But For How Long?
Linear TV has long dominated the marketing mix for pharmaceutical brands and their agencies, but it won’t be long before CTV overrides linear for overall audience share. And unlike linear, CTV offers precise programmatic targeting, making CTV ads more relevant and more cost-effective, writes Marcella Milliet Sciorra, CMO of DeepIntent.
-
FAST Channels Pick Up The Pace Of Original Content; Google Play Store Removes Defense Contractor
Here’s today’s AdExchanger.com news round-up… Want it by email? Sign up here. Not So FAST FAST channels have been slow to develop original content. Most free ad-supported TV (FAST) channels are feasting on the scraps of linear TV. It works because old shows are still new for millions of viewers who didn’t catch them over the […]